Coronavirus disease (COVID-19): Hydroxychloroquine

WHO does not recommend hydroxychloroquine to prevent COVID-19. This recommendation is based on findings from 6 trials, with more than 6000 participants, who did not have COVID-19 and received hydroxychloroquine. Using hydroxychloroquine for prevention had little or no effect on preventing illness, hospitalization or death from COVID-19. Taking hydroxychloroquine to prevent COVID-19 may increase the risk of diarrhoea, nausea, abdominal pain, drowsiness and headache. More information can be found here. 

Hydroxychloroquine is used to treat autoimmune diseases including arthritis. While considered generally safe, several adverse events are associated with its use, and it should only be used under medical supervision.

WHO does not recommend hydroxychloroquine as a treatment for COVID-19. This recommendation is based on findings from 30 trials with more than 10 000 COVID-19 patients. Hydroxychloroquine did not reduce mortality, the need for or duration of mechanical ventilation. Taking hydroxychloroquine to treat COVID-19 may increase the risk of heart rhythm problems, blood and lymph disorders, kidney injury, liver problems and failure. 
More information can be found here.

Hydroxychloroquine is used to treat autoimmune diseases including arthritis. While considered generally safe, several adverse events are associated with its use, and it should only be used under medical supervision.